Mimedx (MDXG) Operating Income (2011 - 2026)

Mimedx has disclosed Operating Income across 16 years of filings, most recently posting -$18.5 million for Q2 2026.

• In Q2 2026, Operating Income fell 249.28% year-over-year to -$18.5 million; the TTM figure through Jun 2026 stood at $8.8 million (down 79.57% YoY), while the FY2025 annual figure was $63.9 million, up 8.53% from the prior year.
• Operating Income came in at -$18.5 million for Q2 2026 at Mimedx, down from -$16.0 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of $23.4 million in Q2 2024 to a low of -$18.5 million in Q2 2026.
• Average Operating Income over 5 years is $6.1 million, with a median of $11.1 million recorded in 2023.
• Year-over-year, Operating Income slumped 2250.24% in 2022 and surged 3981.76% in 2024.
• Over 5 years, Operating Income stood at $11.3 million in 2022, then jumped by 36.95% to $15.5 million in 2023, then decreased by 28.64% to $11.1 million in 2024, then surged by 90.67% to $21.1 million in 2025, then sank by 187.61% to -$18.5 million in 2026.
• Per Business Quant data, the three most recent Operating Income figures were -$18.5 million in Q2 2026, -$16.0 million in Q1 2026, and $21.1 million in Q4 2025.